Word: cancerous
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...easy to see why. More than 30 years after the War on Cancer was declared, malignancies in all parts of the body are still managing to evade the best therapies thrown at them. For some leukemias, survival rates have not budged since the 1970s. To be sure, there are gentler and more sophisticated forms of chemotherapy and radiation, as well as clever new drugs like Gleevec and Herceptin that take better aim at cancerous cells. But those therapies treat all cancer cells as equals. The next generation of treatments, doctors say, needs to recognize and target the root cause...
Such a shift in thinking is already under way, thanks to the special nature of cancer stem cells. Unlike embryonic stem cells, which stir up moral and political passions because they can, in theory, be used to create an entire human being, cancer stem cells are mutated forms of adult stem cells that can only make copies of their own cell type, be it blood or skin or lung tissue. What gives those adult cells their "stemness" is the ability to generate more stem cells like themselves (and thus continue to regenerate blood or skin tissue) and to churn...
...idea that the same process could be at work in cancer originated with leukemia researchers. In a series of studies in the 1990s, scientists began taking leukemia cells from human patients, separating out fractions of those cells and putting them into mice specially bred to tolerate human implants. Some of the cell fractions developed into tumors in the animals, while others did not. That was the first proof that the cells in a cancer were not homogeneous. Some cells were more dangerous than others...
...hope is that once those "stem-defining" proteins are identified, they might be used as targets for drug therapies that could lead to better cancer treatments. Irv Weissman, the developmental biologist at Stanford University who first isolated the blood-forming stem cell, is working on pinpointing just such a suite of proteins for leukemia...
Weissman and others are finding no shortage of targets. For one thing, cancer stem cells seem to be extremely mobile, able to migrate easily from their birthplace to other parts of the body, where they can churn out more stem cells and launch new tumors. Eradicating those cells at their source might help control the spread of cancers like leukemia that flare from the blood to the bone marrow and other tissues. Blocking a stem cell's source of nutrients might be another effective strategy for drug development. Unlike normal stem cells, which tap into many different blood supplies...